Health News Releases

  • Today July 1
May 30, 2024 09:30
TVM Capital Healthcare Announces the Closing of its Saudi Arabia-Focused TVM Healthcare Afiyah Fund
TVM Capital Healthcare, an international healthcare expansion and growth capital investor, today announced the closing of the TVM Healthcare Afiyah Fund LP at approximately USD 250 million, its second
May 29, 2024 11:55
Ferrer Obtains the Distribution Rights for Treprostinil Inhalation Solution Including the Potential Indications for Idiopathic Pulmonary Fibrosis (IPF) and Progressive Pulmonary Fibrosis (PPF)
The international pharmaceutical BCorp company Ferrer continues to strengthen its focus on pulmonary vascular and interstitial lung diseases by announcing the expansion of its current distribution agr
May 28, 2024 14:58
Oncocross and JW Pharmaceutical Team Up on AI-powered Drugs for Cancer and Regeneration
Oncocross, an AI biotech company specializing in drug discovery and development, announced that it has signed a joint research agreement with JW Pharmaceutical to develop new drugs based on the AI pl
May 28, 2024 14:30
Datopotamab deruxtecan showed clinically meaningful overall survival improvement vs. chemotherapy in patients with advanced nonsquamous non-small cell lung cancer in TROPION-Lung01 Phase III trial
High-level overall survival (OS) results from the TROPION-Lung01 Phase III trial, which previously met the dual primary endpoint of progression-free survival (PFS), numerically favoured datopotamab de
May 26, 2024 10:55
European Medicines Agency (EMA) Validates Henlius and Organon Filings for Prolia® and Xgeva® (denosumab) Biosimilar Candidate HLX14
Shanghai Henlius Biotech, Inc. (2696.HK) and Organon (NYSE: OGN) today announced that the European Medicines Agency (EMA) has validated the marketing authorization applications (MAAs) for HLX14, an in
May 24, 2024 14:10
Merck to Showcase Advances in the Science of Cancer With New Data Presented at ASCO 2024
Merck, a leading science and technology company, today announced new research from the company’s diverse oncology portfolio will be presented at the 2024 American Society of Clinical Oncology (ASCO) A
May 23, 2024 14:36
Galderma Launches Restylane® VOLYME™ in China - One of the World’s Fastest Growing Aesthetics Markets
Galderma (SWX:GALD) announced today the launch of its hyaluronic acid injectable filler, Restylane® VOLYME™ in China. The company is also introducing its complementary Shape Up Holistic Individualized
Medscape Education and KDIGO Nephrology Collaboration Accelerates Improvements to Patient Care
May 22, 2024 17:10
Medscape Education and KDIGO Nephrology Collaboration Accelerates Improvements to Patient Care
Ahead of the 61st European Renal Association (ERA) Congress, Medscape Education and KDIGO (Kidney Disease: Improving Global Outcomes) announce an educational collaboration through a series of webinars
May 22, 2024 14:30
AstraZeneca sets ambition to deliver $80 billion Total Revenue by 2030 and sustained growth post 2030
Today AstraZeneca revealed its bold ambition to deliver $80 billion in Total Revenue by 2030, up from $45.8 billion in 2023. This will be achieved through significant growth in its existing oncology,
New, state of the art, clinical trial unit at QPS Miami in South Miami, Florida USA. (Photo: Busines
May 22, 2024 13:40
QPS Expands Clinic in Miami, Florida to Accommodate Increasing Demand for Obesity Trials
QPS, a leading global contract research organization (CRO), continues to expand and align its full-service preclinical, bioanalysis, and clinical capabilities with the evolution of demand for clinical
May 22, 2024 11:35
Leading Pharmaceutical Company Selects Kinaxis to Cure Supply Chain Headaches
Kinaxis (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.kinaxis.com%2Fen&esheet=54001339&newsitemid=20240521977758&lan=en-US&anchor=Kinaxis&index=1&md5=5f9eae6c7e7cdf798bb35930e
(Photo: Business Wire)
May 22, 2024 11:00
Carestream Introduces Image Suite MR 10 Software to Enhance Imaging Experience for CR and DR Imaging Systems
Carestream launches its Image Suite MR 10 Software to help deliver a boost to productivity and efficiency while enabling a more user-friendly imaging experience for radiographers. Carestream’s Imag
Benjamin Binot, P&G Europe Oral Care Senior Vice President, announcing the launch of the Disability
May 16, 2024 16:44
New Award Programme From Oral-B and the International Association for Disability and Oral Health (iADH) Champions Disability Positive Dental Practices Across Europe
Today, on Global Accessibility Awareness Day (GAAD), Oral-B proudly launches the Disability Champions Award Programme as part of its ongoing mission to make oral care more accessible to everybody. In
Brain organoids on electrodes (Photo: Business Wire)
May 16, 2024 16:00
FinalSpark Launches the First Remote Research Platform Using Human Neurons for Biocomputing
FinalSpark, a pioneering Swiss biocomputing startup, has launched the first-ever online platform enabling global researchers to conduct experiments remotely on biological neurons in vitro. The platfor
May 16, 2024 14:20
Optiscan Signs Know-How Agreement with Mayo Clinic
Optiscan Imaging Limited (ASX:OIL) (‘Optiscan’ or ‘The Company’) is pleased to announce that it has entered into a collaboration through a know-how agreement with Mayo Clinic to develop a digital conf
Carestream CEO Todd Clegg (Photo: Business Wire)
May 16, 2024 13:09
Todd Clegg Named Carestream’s Chief Executive Officer
Carestream, a world-leading provider of medical imaging systems and non-destructive testing solutions, announced that Todd Clegg has been named CEO and appointed to the Board of Directors, effective i
May 16, 2024 10:03
MRM Health to Present Positive Clinical Data from MH002 in Ulcerative Colitis at Digestive Disease Week (DDW)
MRM Health NV, a clinical-stage biopharmaceutical company developing innovative therapeutics for inflammatory, CNS and metabolic diseases, today announced it will present positive data for its lead as
May 15, 2024 10:30
Takeda to Present Oncology Portfolio and Pipeline Data at the 2024 ASCO Annual Meeting
Takeda (TSE: 4502/NYSE:TAK) (https://www.takeda.com/investors/overview/) today announced that it will present data from its oncology pipeline and product portfolio at the 60th Annual Meeting of the Am
May 14, 2024 14:10
GRAMINEX®, L.L.C. Final Publication of a Peer Reviewed Clinical Trial with Graminex® Flower Pollen Extract Focusing on Women’s Urinary Incontinence in Current Urology.
Graminex®, L.L.C. is pleased to announce publication of a peer reviewed clinical study with Graminex® Flower Pollen Extract for women’s urinary incontinence and urinary health in Current Urology. The
May 14, 2024 09:55
AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer’s Disease
Takeda (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.takeda.com%2F&esheet=53983823&newsitemid=20240510475155&lan=en-US&anchor=Takeda&index=1&md5=4a403ee030780c54b5ebde46e786f5
May 13, 2024 10:20
Takeda Announces FY2023 Full Year Results and FY2024 Outlook, Affirming Commitment to Late-Stage Pipeline Development and Core Operating Profit Margin Expansion
Takeda (TOKYO:4502/NYSE:TAK) today announced financial results for fiscal year 2023 (period ended March 31, 2024), delivering its Management Guidance for Core Operating Profit and exceeding its Manage
May 10, 2024 14:55
BeiGene Reports First Quarter 2024 Financial Results and Business Updates
BeiGene (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.beigene.com%2F&esheet=53978747&newsitemid=20240508878785&lan=en-US&anchor=BeiGene&index=1&md5=289a1210b11d33d3f6dbd570f8e
May 09, 2024 15:40
LC-Plasma-based Vaccine Research Selected for SCARDA Project
Kirin Holdings Company, Limited (Kirin Holdings)(TOKYO:2503) and National Institute of Infectious Diseases (NIID) are jointly conducting studies to investigate the protective efficacy of L. lactis str
May 09, 2024 13:55
Study Suggests Critical Link Between Residual FLT3-ITD Mutations in Remission and Post-Transplant Outcomes in AML
A groundbreaking research study,[1] sequencing DNA samples from the Pre-MEASURE study[2] strongly indicates that the detection of residual FLT3 internal tandem duplication (ITD) mutations in the blood
May 07, 2024 14:35
Galderma Receives Filing Acceptances for Nemolizumab in Prurigo Nodularis and Atopic Dermatitis in Four Additional Countries
Galderma today announced that it has received filing acceptances for nemolizumab for the treatment of patients with prurigo nodularis and for adolescents and adults with moderate-to-severe atopic derm
25 per page50 per page75 per page100 per page